刘奕明, 杨柳, 曾星, 邓远辉, 冯怡, 梁伟雄. 参麦注射液中人参皂苷Rg1和Re药代动力学研究J. 药学学报, 2005, 40(4): 365-368.
引用本文: 刘奕明, 杨柳, 曾星, 邓远辉, 冯怡, 梁伟雄. 参麦注射液中人参皂苷Rg1和Re药代动力学研究J. 药学学报, 2005, 40(4): 365-368.
LIU Yi-ming, YANG Liu, ZENG Xing, DENG Yuan-hui, FENG Yi, LIANG Wei-xiong. Pharmacokinetics of ginsenosides Rg1 and Re in Shenmai injectionJ. Acta Pharmaceutica Sinica, 2005, 40(4): 365-368.
Citation: LIU Yi-ming, YANG Liu, ZENG Xing, DENG Yuan-hui, FENG Yi, LIANG Wei-xiong. Pharmacokinetics of ginsenosides Rg1 and Re in Shenmai injectionJ. Acta Pharmaceutica Sinica, 2005, 40(4): 365-368.

参麦注射液中人参皂苷Rg1和Re药代动力学研究

Pharmacokinetics of ginsenosides Rg1 and Re in Shenmai injection

  • 摘要: 目的研究参麦注射液中人参皂苷Rg1和Re人体药代动力学。方法采用已建立的LC/MS/MS法同时测定人血浆中人参皂苷Rg1和Re浓度,并计算其药代动力学参数。结果人参皂苷Rg1和Re线性范围为1.023-1 023 μg·L-1和1.05-1 050 μg·L-1,方法回收率在99%-105%和99%-104%,日内、日间RSD值均小于15%。参麦注射液60 mL经静脉滴注后人参皂苷Rg1和Re的药时曲线均符合二房室开放模型,T1/2α分别为0.28 h和0.10 h,T1/2β分别为2.1 h和1.2 h。结论该法简便、灵敏、特异,适用于血浆中人参皂苷Rg1和Re浓度的测定。参麦注射液中人参皂苷Rg1和Re在人体内血药浓度较低,分布和消除速度较快,药代动力学行为符合二房室模型。

     

    Abstract: AimTo study the pharmacokinetics of ginsenosides Rg1 and Re after iv infusion of Shenmai injection in human. MethodsGinsenosides Rg1 and Re in plasma were determined by LC/MS/MS and the pharmacokinetic parameters were calculated. ResultsThe linear regressive curves were obtained in the range of 1.023-1 023 μg·L-1 for Rg1 and 1.05-1 050 μg·L-1 for Re. Recoveries using the method of Rg1 and Re were 99%-105% and 99%-104%, respectively. The within-day and between-day RSDs were less than 15%. After iv infusion of Shenmai injection to volunteers, the concentration-time curves of Rg1 and Re fitted to the two-compartment model, T1/2α were 0.28 h and 0.10 h, T1/2β were 2.1 h and 1.2 h, respectively. ConclusionThe method is specific, simple, sensitive and suitable for the measurement of plasma Rg1 and Re concentrations. The distribution and elimination of Rg1 and Re were rapid after iv infusion of Shenmai injection in volunteers, the pharmacokinetic characteristics were fitted with the two-compartment model.

     

/

返回文章
返回